71 related articles for article (PubMed ID: 16550914)
1. Splicing abnormalities in congenital myasthenic syndromes.
Ohno K; Engel AG
Acta Myol; 2005 Oct; 24(2):50-4. PubMed ID: 16550914
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of splicing errors caused by CHRNE mutations affecting introns and intron/exon boundaries.
Ohno K; Tsujino A; Shen XM; Milone M; Engel AG
J Med Genet; 2005 Aug; 42(8):e53. PubMed ID: 16061559
[TBL] [Abstract][Full Text] [Related]
3. A frameshifting mutation in CHRNE unmasks skipping of the preceding exon.
Ohno K; Milone M; Shen XM; Engel AG
Hum Mol Genet; 2003 Dec; 12(23):3055-66. PubMed ID: 14532324
[TBL] [Abstract][Full Text] [Related]
4. A synonymous CHRNE mutation responsible for an aberrant splicing leading to congenital myasthenic syndrome.
Richard P; Gaudon K; Fournier E; Jackson C; Bauché S; Haddad H; Koenig J; Echenne B; Hantaï D; Eymard B
Neuromuscul Disord; 2007 May; 17(5):409-14. PubMed ID: 17363247
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotide-mediated exon skipping of CHRNA1 pre-mRNA as potential therapy for Congenital Myasthenic Syndromes.
Tei S; Ishii HT; Mitsuhashi H; Ishiura S
Biochem Biophys Res Commun; 2015 Jun; 461(3):481-6. PubMed ID: 25888793
[TBL] [Abstract][Full Text] [Related]
6. Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A-->G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing?
Ohno K; Brengman JM; Felice KJ; Cornblath DR; Engel AG
Am J Hum Genet; 1999 Sep; 65(3):635-44. PubMed ID: 10441569
[TBL] [Abstract][Full Text] [Related]
7. An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome.
Müller JS; Stucka R; Neudecker S; Zierz S; Schmidt C; Huebner A; Lochmüller H; Abicht A
Neurology; 2005 Aug; 65(3):463-5. PubMed ID: 16087917
[TBL] [Abstract][Full Text] [Related]
8. Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene.
Tran VK; Takeshima Y; Zhang Z; Yagi M; Nishiyama A; Habara Y; Matsuo M
J Med Genet; 2006 Dec; 43(12):924-30. PubMed ID: 16738009
[TBL] [Abstract][Full Text] [Related]
9. SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome.
Rahman MA; Azuma Y; Nasrin F; Takeda J; Nazim M; Bin Ahsan K; Masuda A; Engel AG; Ohno K
Sci Rep; 2015 Aug; 5():13208. PubMed ID: 26282582
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
11. Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction.
Ohno K; Rahman MA; Nazim M; Nasrin F; Lin Y; Takeda JI; Masuda A
J Neurochem; 2017 Aug; 142 Suppl 2():64-72. PubMed ID: 28072465
[TBL] [Abstract][Full Text] [Related]
12. hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome.
Masuda A; Shen XM; Ito M; Matsuura T; Engel AG; Ohno K
Hum Mol Genet; 2008 Dec; 17(24):4022-35. PubMed ID: 18806275
[TBL] [Abstract][Full Text] [Related]
13. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
[TBL] [Abstract][Full Text] [Related]
14. Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin-Lowry syndrome.
Zeniou M; Gattoni R; Hanauer A; Stévenin J
Nucleic Acids Res; 2004; 32(3):1214-23. PubMed ID: 14973203
[TBL] [Abstract][Full Text] [Related]
15. Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome.
Bian Y; Masuda A; Matsuura T; Ito M; Okushin K; Engel AG; Ohno K
Hum Mol Genet; 2009 Apr; 18(7):1229-37. PubMed ID: 19147685
[TBL] [Abstract][Full Text] [Related]
16. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
17. A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers.
Rinz CJ; Lennon VA; James F; Thoreson JB; Tsai KL; Starr-Moss AN; Humphries HD; Guo LT; Palmer AC; Clark LA; Shelton GD
Neuromuscul Disord; 2015 Dec; 25(12):921-7. PubMed ID: 26429099
[TBL] [Abstract][Full Text] [Related]
18. Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.
Aznarez I; Zielenski J; Rommens JM; Blencowe BJ; Tsui LC
J Med Genet; 2007 May; 44(5):341-6. PubMed ID: 17475917
[TBL] [Abstract][Full Text] [Related]
19. First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome.
Ben Mahmoud A; Siala O; Mansour RB; Driss F; Baklouti-Gargouri S; Mkaouar-Rebai E; Belguith N; Fakhfakh F
Gene; 2013 Dec; 532(1):13-7. PubMed ID: 23954224
[TBL] [Abstract][Full Text] [Related]
20. The architecture of pre-mRNAs affects mechanisms of splice-site pairing.
Fox-Walsh KL; Dou Y; Lam BJ; Hung SP; Baldi PF; Hertel KJ
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16176-81. PubMed ID: 16260721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
